Abstract
In 189 opioid-dependent subjects on methadone maintenance treatment in Barcelona (Spain), we assessed the prevalence of co-occurrence substance use and non-substance-use disorders (dual diagnosis) by the Psychiatric Research Interview for Substance and Mental Disorders [PRISM], and the impact on quality of life (HRQoL) by the SF-12 (PCS-12 and MCS-12 scales). Rates of substance and non-substance-use diagnoses were 59% and 32%, respectively. Mean scores for PCS-12 and MCS-12 were 44.1+/-10.1 and 39.9+/-11.7, without differences by presence or absence of dual diagnosis. Heroin users on methadone treatment showed a high prevalence of dual diagnosis and a very impaired HRQoL.
Publication types
-
Comparative Study
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antisocial Personality Disorder / diagnosis
-
Antisocial Personality Disorder / epidemiology
-
Antisocial Personality Disorder / psychology
-
Borderline Personality Disorder / diagnosis
-
Borderline Personality Disorder / epidemiology
-
Borderline Personality Disorder / psychology
-
Comorbidity
-
Diagnosis, Dual (Psychiatry)
-
Female
-
Health Status*
-
Heroin Dependence / diagnosis*
-
Heroin Dependence / epidemiology
-
Heroin Dependence / prevention & control
-
Humans
-
Male
-
Mental Disorders / diagnosis*
-
Mental Disorders / epidemiology
-
Mental Disorders / psychology
-
Methadone / therapeutic use
-
Patient Acceptance of Health Care / psychology
-
Prevalence
-
Psychiatric Status Rating Scales / statistics & numerical data
-
Quality of Life*
-
Spain / epidemiology
-
Substance Abuse Treatment Centers / statistics & numerical data